CXCL12 and chronic kidney disease: For chronic kidney disease, Chen et al. found that: SDF-1 mRNA doubled in human focal segmental glomerulosclerosis, which might be due to the use of angiotentin converting enzyme inhibitor; and local SDF-1 delivery induces glomerular eNOS activation in a CXCR4-dependent manner.